Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Epogen

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Epogen was produced by Amgen.

Sourcing R&D innovation: why pharma companies need to evolve their business models

Sourcing R&D innovation: why pharma companies need to evolve their business models

Amgen developed a portfolio of supportive cancer care drugs including Epogen, Neupogen and Aranesp, and Endo Pharmaceuticals developed a pipeline of pain products that includes Lidoderm, Percocet and Opana.

AZ preps new roxadustat filings, though data foxes investors

AZ preps new roxadustat filings, though data foxes investors Epoetin alfa is sold by Amgen as Epogen and Janssen as Procrit, but these brands were joined by Pfizer’s lower-cost biosimilar Retacrit last year.

China first market to approve AZ’s kidney drug roxadustat

China first market to approve AZ’s kidney drug roxadustat as Amgen’s Epogen (epoetin alfa) and Aranesp (darbepoetin alfa).

Pfizer gets FDA panel recommendation for biosimilar EPO

Pfizer gets FDA panel recommendation for biosimilar EPO Product could be the first direct competitor to Epogen and Procrit in the US. ... If the FDA follows its panel's advice – which it generally does – Pfizer will have a direct competitor to Amgen's Epogen and Johnson &Johnson Procrit blockbuster brands

Novartis gets FDA panel backing for biosimilar Enbrel

Novartis gets FDA panel backing for biosimilar Enbrel The company has several other biosimilars in clinical development, including copycat versions of Humira, Roche's MabThera/Rituxan (rituximab), Amgen's Epogen (epoetin alfa) and Neulasta (pegfilgrastim) and Johnson &Johnson's

1 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....